Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2025-12-26 @ 11:11 AM
NCT ID:
NCT07227428
Eligibility Criteria:
Inclusion Criteria:
* Males or females ≥19 years of age at time of consent
* Body weight \< 90kg
* Have a diagnosis of RA per the 2010 ACR/EULAR criteria for at least 6 months
* Disease activity of rheumatoid arthritis has been stable for at least 4 weeks prior to randomization (DAS28-CRP ≤ 3.2)
* The patient has been taking a stable dose of prednisolone equivalent ≤ 5 mg/day for at least 12 weeks prior to randomization
* The dose of corticosteroids has not changed during the 4 weeks prior to randomization
Exclusion Criteria:
* History of major surgery within 8 weeks prior to screening
* Increase in the dose of antirheumatic drugs within 4 weeks prior to screening due to worsening arthritis
* Pregnant or breastfeeding
* RA functional class IV, requiring confinement to bed or wheelchair
* History of primary or secondary adrenal insufficiency
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT07227428
Study Brief:
Protocol Section:
NCT07227428